| Followers | 22 |
| Posts | 1626 |
| Boards Moderated | 1 |
| Alias Born | 09/25/2018 |
Friday, October 31, 2025 11:39:04 PM
Senti, you aren't missing anything.
There was a fair amount wrong in that post and the hypothetical examples. A rather painful to read attempt to justify claims of manipulation.
There have not been any exchange traded options since nwbo left NASDAQ.
Company options were issued to employees. Most are subject to blocker agreements, and out of the money (average exercise price $0.35)
The remaining warrants are effectively all insiders as well. Of 93 million remaining, 92 million are subject to blocker agreements, so clearly insiders,
mostly LP + Les' estate. These are also out of the money (average exercise price $0.27).
There was a fair amount wrong in that post and the hypothetical examples. A rather painful to read attempt to justify claims of manipulation.
There have not been any exchange traded options since nwbo left NASDAQ.
Company options were issued to employees. Most are subject to blocker agreements, and out of the money (average exercise price $0.35)
The remaining warrants are effectively all insiders as well. Of 93 million remaining, 92 million are subject to blocker agreements, so clearly insiders,
mostly LP + Les' estate. These are also out of the money (average exercise price $0.27).
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
